Propellus Inc.
Propellus Inc. (PRPS) Stock Competitors & Peer Comparison
See (PRPS) competitors and their performances in Stock Market.
Peer Comparison Table: Financial - Credit Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PRPS | $1.94 | -0.08% | 17.5M | -1.28 | -$1.52 | N/A |
| AGRIP | $99.80 | +0.05% | 46.8B | 103.63 | $0.96 | N/A |
| ORXCF | $35.25 | +2.92% | 38.7B | 13.25 | $2.66 | +2.95% |
| MIUFY | $20.00 | +11.54% | 14.4B | 13.89 | $1.44 | +2.14% |
| MIUFF | $7.50 | +0.00% | 10.8B | 12.30 | $0.61 | +3.91% |
| FREJO | $16.50 | +0.00% | 10.7B | -181.32 | -$0.09 | N/A |
| FREJP | $15.45 | +2.18% | 10B | N/A | N/A | N/A |
| EDNMY | $12.80 | +3.64% | 5.9B | 10.33 | $1.22 | +5.55% |
| EDNMF | $21.00 | +0.00% | 4.9B | 8.61 | $2.44 | +6.62% |
| CMPRF | $2.51 | +0.00% | 4B | 8.37 | $0.30 | +4.04% |
Stock Comparison
PRPS vs AGRIP Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, AGRIP has a market cap of 46.8B. Regarding current trading prices, PRPS is priced at $1.94, while AGRIP trades at $99.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas AGRIP's P/E ratio is 103.63. In terms of profitability, PRPS's ROE is -0.76%, compared to AGRIP's ROE of +0.11%. Regarding short-term risk, PRPS and AGRIP have similar daily volatility (0.00).Check AGRIP's competition here
PRPS vs ORXCF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, ORXCF has a market cap of 38.7B. Regarding current trading prices, PRPS is priced at $1.94, while ORXCF trades at $35.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas ORXCF's P/E ratio is 13.25. In terms of profitability, PRPS's ROE is -0.76%, compared to ORXCF's ROE of +0.11%. Regarding short-term risk, PRPS is less volatile compared to ORXCF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check ORXCF's competition here
PRPS vs MIUFY Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, MIUFY has a market cap of 14.4B. Regarding current trading prices, PRPS is priced at $1.94, while MIUFY trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas MIUFY's P/E ratio is 13.89. In terms of profitability, PRPS's ROE is -0.76%, compared to MIUFY's ROE of +0.10%. Regarding short-term risk, PRPS is less volatile compared to MIUFY. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check MIUFY's competition here
PRPS vs MIUFF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, MIUFF has a market cap of 10.8B. Regarding current trading prices, PRPS is priced at $1.94, while MIUFF trades at $7.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas MIUFF's P/E ratio is 12.30. In terms of profitability, PRPS's ROE is -0.76%, compared to MIUFF's ROE of +0.10%. Regarding short-term risk, PRPS and MIUFF have similar daily volatility (0.00).Check MIUFF's competition here
PRPS vs FREJO Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, FREJO has a market cap of 10.7B. Regarding current trading prices, PRPS is priced at $1.94, while FREJO trades at $16.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas FREJO's P/E ratio is -181.32. In terms of profitability, PRPS's ROE is -0.76%, compared to FREJO's ROE of +0.17%. Regarding short-term risk, PRPS and FREJO have similar daily volatility (0.00).Check FREJO's competition here
PRPS vs FREJP Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, FREJP has a market cap of 10B. Regarding current trading prices, PRPS is priced at $1.94, while FREJP trades at $15.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas FREJP's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to FREJP's ROE of +0.17%. Regarding short-term risk, PRPS is less volatile compared to FREJP. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check FREJP's competition here
PRPS vs EDNMY Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, EDNMY has a market cap of 5.9B. Regarding current trading prices, PRPS is priced at $1.94, while EDNMY trades at $12.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas EDNMY's P/E ratio is 10.33. In terms of profitability, PRPS's ROE is -0.76%, compared to EDNMY's ROE of -0.51%. Regarding short-term risk, PRPS is less volatile compared to EDNMY. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check EDNMY's competition here
PRPS vs EDNMF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, EDNMF has a market cap of 4.9B. Regarding current trading prices, PRPS is priced at $1.94, while EDNMF trades at $21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas EDNMF's P/E ratio is 8.61. In terms of profitability, PRPS's ROE is -0.76%, compared to EDNMF's ROE of -0.53%. Regarding short-term risk, PRPS and EDNMF have similar daily volatility (0.00).Check EDNMF's competition here
PRPS vs CMPRF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, CMPRF has a market cap of 4B. Regarding current trading prices, PRPS is priced at $1.94, while CMPRF trades at $2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas CMPRF's P/E ratio is 8.37. In terms of profitability, PRPS's ROE is -0.76%, compared to CMPRF's ROE of +0.25%. Regarding short-term risk, PRPS and CMPRF have similar daily volatility (0.00).Check CMPRF's competition here
PRPS vs CSASF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, CSASF has a market cap of 3.4B. Regarding current trading prices, PRPS is priced at $1.94, while CSASF trades at $23.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas CSASF's P/E ratio is 8.34. In terms of profitability, PRPS's ROE is -0.76%, compared to CSASF's ROE of +0.08%. Regarding short-term risk, PRPS and CSASF have similar daily volatility (0.00).Check CSASF's competition here
PRPS vs MAURY Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, MAURY has a market cap of 3.3B. Regarding current trading prices, PRPS is priced at $1.94, while MAURY trades at $37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas MAURY's P/E ratio is 17.96. In terms of profitability, PRPS's ROE is -0.76%, compared to MAURY's ROE of +0.12%. Regarding short-term risk, PRPS and MAURY have similar daily volatility (0.00).Check MAURY's competition here
PRPS vs MAURF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, MAURF has a market cap of 3.2B. Regarding current trading prices, PRPS is priced at $1.94, while MAURF trades at $17.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas MAURF's P/E ratio is 17.57. In terms of profitability, PRPS's ROE is -0.76%, compared to MAURF's ROE of +0.12%. Regarding short-term risk, PRPS is less volatile compared to MAURF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check MAURF's competition here
PRPS vs ZNKKY Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, ZNKKY has a market cap of 2.9B. Regarding current trading prices, PRPS is priced at $1.94, while ZNKKY trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas ZNKKY's P/E ratio is 14.23. In terms of profitability, PRPS's ROE is -0.76%, compared to ZNKKY's ROE of +0.14%. Regarding short-term risk, PRPS and ZNKKY have similar daily volatility (0.00).Check ZNKKY's competition here
PRPS vs KGTHY Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, KGTHY has a market cap of 2.5B. Regarding current trading prices, PRPS is priced at $1.94, while KGTHY trades at $9.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas KGTHY's P/E ratio is 10.30. In terms of profitability, PRPS's ROE is -0.76%, compared to KGTHY's ROE of +0.18%. Regarding short-term risk, PRPS and KGTHY have similar daily volatility (0.00).Check KGTHY's competition here
PRPS vs KRKKF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, KRKKF has a market cap of 2.5B. Regarding current trading prices, PRPS is priced at $1.94, while KRKKF trades at $126.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas KRKKF's P/E ratio is 9.48. In terms of profitability, PRPS's ROE is -0.76%, compared to KRKKF's ROE of +0.21%. Regarding short-term risk, PRPS and KRKKF have similar daily volatility (0.00).Check KRKKF's competition here
PRPS vs ZIZTF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, ZIZTF has a market cap of 2.5B. Regarding current trading prices, PRPS is priced at $1.94, while ZIZTF trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas ZIZTF's P/E ratio is 32.50. In terms of profitability, PRPS's ROE is -0.76%, compared to ZIZTF's ROE of +0.16%. Regarding short-term risk, PRPS is less volatile compared to ZIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check ZIZTF's competition here
PRPS vs AATRL Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, AATRL has a market cap of 2.1B. Regarding current trading prices, PRPS is priced at $1.94, while AATRL trades at $73.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas AATRL's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to AATRL's ROE of +0.29%. Regarding short-term risk, PRPS is less volatile compared to AATRL. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check AATRL's competition here
PRPS vs AEOJF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, AEOJF has a market cap of 1.9B. Regarding current trading prices, PRPS is priced at $1.94, while AEOJF trades at $8.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas AEOJF's P/E ratio is 15.58. In terms of profitability, PRPS's ROE is -0.76%, compared to AEOJF's ROE of +0.04%. Regarding short-term risk, PRPS and AEOJF have similar daily volatility (0.00).Check AEOJF's competition here
PRPS vs HYPOF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, HYPOF has a market cap of 1.5B. Regarding current trading prices, PRPS is priced at $1.94, while HYPOF trades at $225.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas HYPOF's P/E ratio is 88.93. In terms of profitability, PRPS's ROE is -0.76%, compared to HYPOF's ROE of +0.07%. Regarding short-term risk, PRPS and HYPOF have similar daily volatility (0.00).Check HYPOF's competition here
PRPS vs AIFLF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, AIFLF has a market cap of 1.5B. Regarding current trading prices, PRPS is priced at $1.94, while AIFLF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas AIFLF's P/E ratio is 10.17. In terms of profitability, PRPS's ROE is -0.76%, compared to AIFLF's ROE of +0.15%. Regarding short-term risk, PRPS and AIFLF have similar daily volatility (0.00).Check AIFLF's competition here
PRPS vs UMTAF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, UMTAF has a market cap of 1.1B. Regarding current trading prices, PRPS is priced at $1.94, while UMTAF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas UMTAF's P/E ratio is 4.58. In terms of profitability, PRPS's ROE is -0.76%, compared to UMTAF's ROE of +0.13%. Regarding short-term risk, PRPS and UMTAF have similar daily volatility (0.00).Check UMTAF's competition here
PRPS vs SHGKY Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, SHGKY has a market cap of 978.2M. Regarding current trading prices, PRPS is priced at $1.94, while SHGKY trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas SHGKY's P/E ratio is 4.81. In terms of profitability, PRPS's ROE is -0.76%, compared to SHGKY's ROE of +0.07%. Regarding short-term risk, PRPS and SHGKY have similar daily volatility (0.00).Check SHGKY's competition here
PRPS vs ALEDY Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, ALEDY has a market cap of 801.1M. Regarding current trading prices, PRPS is priced at $1.94, while ALEDY trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas ALEDY's P/E ratio is -8.14. In terms of profitability, PRPS's ROE is -0.76%, compared to ALEDY's ROE of +0.03%. Regarding short-term risk, PRPS is less volatile compared to ALEDY. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check ALEDY's competition here
PRPS vs FAVO Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, FAVO has a market cap of 757.4M. Regarding current trading prices, PRPS is priced at $1.94, while FAVO trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas FAVO's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to FAVO's ROE of +0.35%. Regarding short-term risk, PRPS is less volatile compared to FAVO. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check FAVO's competition here
PRPS vs PRLPF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, PRLPF has a market cap of 690.8M. Regarding current trading prices, PRPS is priced at $1.94, while PRLPF trades at $17.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas PRLPF's P/E ratio is 13.10. In terms of profitability, PRPS's ROE is -0.76%, compared to PRLPF's ROE of +0.22%. Regarding short-term risk, PRPS and PRLPF have similar daily volatility (0.00).Check PRLPF's competition here
PRPS vs INJJF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, INJJF has a market cap of 689.4M. Regarding current trading prices, PRPS is priced at $1.94, while INJJF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas INJJF's P/E ratio is -4.18. In terms of profitability, PRPS's ROE is -0.76%, compared to INJJF's ROE of -0.15%. Regarding short-term risk, PRPS and INJJF have similar daily volatility (0.00).Check INJJF's competition here
PRPS vs AIFLY Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, AIFLY has a market cap of 670.6M. Regarding current trading prices, PRPS is priced at $1.94, while AIFLY trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas AIFLY's P/E ratio is 7.37. In terms of profitability, PRPS's ROE is -0.76%, compared to AIFLY's ROE of +0.12%. Regarding short-term risk, PRPS and AIFLY have similar daily volatility (0.00).Check AIFLY's competition here
PRPS vs ECNCF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, ECNCF has a market cap of 636.7M. Regarding current trading prices, PRPS is priced at $1.94, while ECNCF trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas ECNCF's P/E ratio is 45.20. In terms of profitability, PRPS's ROE is -0.76%, compared to ECNCF's ROE of +0.10%. Regarding short-term risk, PRPS and ECNCF have similar daily volatility (0.00).Check ECNCF's competition here
PRPS vs FDCHF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, FDCHF has a market cap of 622.6M. Regarding current trading prices, PRPS is priced at $1.94, while FDCHF trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas FDCHF's P/E ratio is 109.00. In terms of profitability, PRPS's ROE is -0.76%, compared to FDCHF's ROE of +0.22%. Regarding short-term risk, PRPS is less volatile compared to FDCHF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check FDCHF's competition here
PRPS vs SWRD Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, SWRD has a market cap of 621.3M. Regarding current trading prices, PRPS is priced at $1.94, while SWRD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas SWRD's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to SWRD's ROE of N/A. Regarding short-term risk, PRPS is less volatile compared to SWRD. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check SWRD's competition here
PRPS vs BFFBF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, BFFBF has a market cap of 483.7M. Regarding current trading prices, PRPS is priced at $1.94, while BFFBF trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas BFFBF's P/E ratio is -26.13. In terms of profitability, PRPS's ROE is -0.76%, compared to BFFBF's ROE of N/A. Regarding short-term risk, PRPS and BFFBF have similar daily volatility (0.00).Check BFFBF's competition here
PRPS vs IPFPF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, IPFPF has a market cap of 473.1M. Regarding current trading prices, PRPS is priced at $1.94, while IPFPF trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas IPFPF's P/E ratio is 5.24. In terms of profitability, PRPS's ROE is -0.76%, compared to IPFPF's ROE of +0.10%. Regarding short-term risk, PRPS is less volatile compared to IPFPF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check IPFPF's competition here
PRPS vs EHMEF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, EHMEF has a market cap of 372.6M. Regarding current trading prices, PRPS is priced at $1.94, while EHMEF trades at $23.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas EHMEF's P/E ratio is -2.94. In terms of profitability, PRPS's ROE is -0.76%, compared to EHMEF's ROE of -0.16%. Regarding short-term risk, PRPS is less volatile compared to EHMEF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check EHMEF's competition here
PRPS vs EGTIF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, EGTIF has a market cap of 350M. Regarding current trading prices, PRPS is priced at $1.94, while EGTIF trades at $7.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas EGTIF's P/E ratio is 16.42. In terms of profitability, PRPS's ROE is -0.76%, compared to EGTIF's ROE of +0.17%. Regarding short-term risk, PRPS and EGTIF have similar daily volatility (0.00).Check EGTIF's competition here
PRPS vs IMMFF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, IMMFF has a market cap of 341.8M. Regarding current trading prices, PRPS is priced at $1.94, while IMMFF trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas IMMFF's P/E ratio is 1.00. In terms of profitability, PRPS's ROE is -0.76%, compared to IMMFF's ROE of +0.67%. Regarding short-term risk, PRPS is less volatile compared to IMMFF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check IMMFF's competition here
PRPS vs ITJTY Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, ITJTY has a market cap of 331.2M. Regarding current trading prices, PRPS is priced at $1.94, while ITJTY trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas ITJTY's P/E ratio is -1.53. In terms of profitability, PRPS's ROE is -0.76%, compared to ITJTY's ROE of -0.11%. Regarding short-term risk, PRPS is less volatile compared to ITJTY. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check ITJTY's competition here
PRPS vs GCSSF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, GCSSF has a market cap of 302.1M. Regarding current trading prices, PRPS is priced at $1.94, while GCSSF trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas GCSSF's P/E ratio is 13.40. In terms of profitability, PRPS's ROE is -0.76%, compared to GCSSF's ROE of +0.09%. Regarding short-term risk, PRPS is less volatile compared to GCSSF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check GCSSF's competition here
PRPS vs CFNB Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, CFNB has a market cap of 284.9M. Regarding current trading prices, PRPS is priced at $1.94, while CFNB trades at $31.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas CFNB's P/E ratio is 6.08. In terms of profitability, PRPS's ROE is -0.76%, compared to CFNB's ROE of +0.06%. Regarding short-term risk, PRPS is less volatile compared to CFNB. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check CFNB's competition here
PRPS vs NECA Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, NECA has a market cap of 275M. Regarding current trading prices, PRPS is priced at $1.94, while NECA trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas NECA's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to NECA's ROE of +0.62%. Regarding short-term risk, PRPS is less volatile compared to NECA. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check NECA's competition here
PRPS vs CHFHF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, CHFHF has a market cap of 202.9M. Regarding current trading prices, PRPS is priced at $1.94, while CHFHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas CHFHF's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to CHFHF's ROE of -0.00%. Regarding short-term risk, PRPS is less volatile compared to CHFHF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check CHFHF's competition here
PRPS vs SEZNL Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, SEZNL has a market cap of 180.1M. Regarding current trading prices, PRPS is priced at $1.94, while SEZNL trades at $14.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas SEZNL's P/E ratio is -1.19. In terms of profitability, PRPS's ROE is -0.76%, compared to SEZNL's ROE of +0.91%. Regarding short-term risk, PRPS and SEZNL have similar daily volatility (0.00).Check SEZNL's competition here
PRPS vs FPLPF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, FPLPF has a market cap of 161.4M. Regarding current trading prices, PRPS is priced at $1.94, while FPLPF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas FPLPF's P/E ratio is 15.82. In terms of profitability, PRPS's ROE is -0.76%, compared to FPLPF's ROE of +0.02%. Regarding short-term risk, PRPS is less volatile compared to FPLPF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check FPLPF's competition here
PRPS vs RYTTF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, RYTTF has a market cap of 34.2M. Regarding current trading prices, PRPS is priced at $1.94, while RYTTF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas RYTTF's P/E ratio is -1.83. In terms of profitability, PRPS's ROE is -0.76%, compared to RYTTF's ROE of -1.45%. Regarding short-term risk, PRPS and RYTTF have similar daily volatility (0.00).Check RYTTF's competition here
PRPS vs YUANF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, YUANF has a market cap of 26.9M. Regarding current trading prices, PRPS is priced at $1.94, while YUANF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas YUANF's P/E ratio is 0.00. In terms of profitability, PRPS's ROE is -0.76%, compared to YUANF's ROE of +2.40%. Regarding short-term risk, PRPS and YUANF have similar daily volatility (0.00).Check YUANF's competition here
PRPS vs FIGI Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, FIGI has a market cap of 22.8M. Regarding current trading prices, PRPS is priced at $1.94, while FIGI trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas FIGI's P/E ratio is -68.33. In terms of profitability, PRPS's ROE is -0.76%, compared to FIGI's ROE of -0.27%. Regarding short-term risk, PRPS and FIGI have similar daily volatility (0.00).Check FIGI's competition here
PRPS vs IOUFF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, IOUFF has a market cap of 17.7M. Regarding current trading prices, PRPS is priced at $1.94, while IOUFF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas IOUFF's P/E ratio is -5.36. In terms of profitability, PRPS's ROE is -0.76%, compared to IOUFF's ROE of +0.00%. Regarding short-term risk, PRPS and IOUFF have similar daily volatility (0.00).Check IOUFF's competition here
PRPS vs AMSA Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, AMSA has a market cap of 10.5M. Regarding current trading prices, PRPS is priced at $1.94, while AMSA trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas AMSA's P/E ratio is -8.00. In terms of profitability, PRPS's ROE is -0.76%, compared to AMSA's ROE of N/A. Regarding short-term risk, PRPS and AMSA have similar daily volatility (0.00).Check AMSA's competition here
PRPS vs MRBLF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, MRBLF has a market cap of 9.6M. Regarding current trading prices, PRPS is priced at $1.94, while MRBLF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas MRBLF's P/E ratio is -5.00. In terms of profitability, PRPS's ROE is -0.76%, compared to MRBLF's ROE of +0.06%. Regarding short-term risk, PRPS is less volatile compared to MRBLF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check MRBLF's competition here
PRPS vs ACCFF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, ACCFF has a market cap of 8.7M. Regarding current trading prices, PRPS is priced at $1.94, while ACCFF trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas ACCFF's P/E ratio is -0.40. In terms of profitability, PRPS's ROE is -0.76%, compared to ACCFF's ROE of -0.42%. Regarding short-term risk, PRPS and ACCFF have similar daily volatility (0.00).Check ACCFF's competition here
PRPS vs SPFX Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, SPFX has a market cap of 6.2M. Regarding current trading prices, PRPS is priced at $1.94, while SPFX trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas SPFX's P/E ratio is 7.07. In terms of profitability, PRPS's ROE is -0.76%, compared to SPFX's ROE of +0.15%. Regarding short-term risk, PRPS and SPFX have similar daily volatility (0.00).Check SPFX's competition here
PRPS vs GWSFF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, GWSFF has a market cap of 6.1M. Regarding current trading prices, PRPS is priced at $1.94, while GWSFF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas GWSFF's P/E ratio is -12.44. In terms of profitability, PRPS's ROE is -0.76%, compared to GWSFF's ROE of +2.83%. Regarding short-term risk, PRPS and GWSFF have similar daily volatility (0.00).Check GWSFF's competition here
PRPS vs MBDC Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, MBDC has a market cap of 3.2M. Regarding current trading prices, PRPS is priced at $1.94, while MBDC trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas MBDC's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to MBDC's ROE of N/A. Regarding short-term risk, PRPS is less volatile compared to MBDC. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check MBDC's competition here
PRPS vs FNNZF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, FNNZF has a market cap of 2.9M. Regarding current trading prices, PRPS is priced at $1.94, while FNNZF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas FNNZF's P/E ratio is 0.14. In terms of profitability, PRPS's ROE is -0.76%, compared to FNNZF's ROE of +0.07%. Regarding short-term risk, PRPS is less volatile compared to FNNZF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check FNNZF's competition here
PRPS vs XSHLF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, XSHLF has a market cap of 2.7M. Regarding current trading prices, PRPS is priced at $1.94, while XSHLF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas XSHLF's P/E ratio is -0.86. In terms of profitability, PRPS's ROE is -0.76%, compared to XSHLF's ROE of -1.31%. Regarding short-term risk, PRPS is less volatile compared to XSHLF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check XSHLF's competition here
PRPS vs KYNC Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, KYNC has a market cap of 1.8M. Regarding current trading prices, PRPS is priced at $1.94, while KYNC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas KYNC's P/E ratio is 0.03. In terms of profitability, PRPS's ROE is -0.76%, compared to KYNC's ROE of -0.28%. Regarding short-term risk, PRPS is less volatile compared to KYNC. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check KYNC's competition here
PRPS vs CUROQ Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, CUROQ has a market cap of 1.7M. Regarding current trading prices, PRPS is priced at $1.94, while CUROQ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas CUROQ's P/E ratio is -0.01. In terms of profitability, PRPS's ROE is -0.76%, compared to CUROQ's ROE of N/A. Regarding short-term risk, PRPS and CUROQ have similar daily volatility (0.00).Check CUROQ's competition here
PRPS vs CHWWF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, CHWWF has a market cap of 1.4M. Regarding current trading prices, PRPS is priced at $1.94, while CHWWF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas CHWWF's P/E ratio is -0.00. In terms of profitability, PRPS's ROE is -0.76%, compared to CHWWF's ROE of -0.15%. Regarding short-term risk, PRPS and CHWWF have similar daily volatility (0.00).Check CHWWF's competition here
PRPS vs CAFI Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, CAFI has a market cap of 1.1M. Regarding current trading prices, PRPS is priced at $1.94, while CAFI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas CAFI's P/E ratio is -0.00. In terms of profitability, PRPS's ROE is -0.76%, compared to CAFI's ROE of +0.01%. Regarding short-term risk, PRPS is less volatile compared to CAFI. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check CAFI's competition here
PRPS vs ATNPQ Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, ATNPQ has a market cap of 925.8K. Regarding current trading prices, PRPS is priced at $1.94, while ATNPQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas ATNPQ's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to ATNPQ's ROE of +24.88%. Regarding short-term risk, PRPS is less volatile compared to ATNPQ. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check ATNPQ's competition here
PRPS vs AIJTY Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, AIJTY has a market cap of 841.1K. Regarding current trading prices, PRPS is priced at $1.94, while AIJTY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas AIJTY's P/E ratio is 3.65. In terms of profitability, PRPS's ROE is -0.76%, compared to AIJTY's ROE of +0.08%. Regarding short-term risk, PRPS is less volatile compared to AIJTY. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check AIJTY's competition here
PRPS vs CBRJ Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, CBRJ has a market cap of 415.6K. Regarding current trading prices, PRPS is priced at $1.94, while CBRJ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas CBRJ's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to CBRJ's ROE of N/A. Regarding short-term risk, PRPS and CBRJ have similar daily volatility (0.00).Check CBRJ's competition here
PRPS vs CFGX Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, CFGX has a market cap of 315.9K. Regarding current trading prices, PRPS is priced at $1.94, while CFGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas CFGX's P/E ratio is -0.01. In terms of profitability, PRPS's ROE is -0.76%, compared to CFGX's ROE of +0.10%. Regarding short-term risk, PRPS and CFGX have similar daily volatility (0.00).Check CFGX's competition here
PRPS vs BCAP Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, BCAP has a market cap of 284.2K. Regarding current trading prices, PRPS is priced at $1.94, while BCAP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas BCAP's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to BCAP's ROE of +1.05%. Regarding short-term risk, PRPS and BCAP have similar daily volatility (0.00).Check BCAP's competition here
PRPS vs RMIAF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, RMIAF has a market cap of 220K. Regarding current trading prices, PRPS is priced at $1.94, while RMIAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas RMIAF's P/E ratio is 0.14. In terms of profitability, PRPS's ROE is -0.76%, compared to RMIAF's ROE of +0.06%. Regarding short-term risk, PRPS is less volatile compared to RMIAF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check RMIAF's competition here
PRPS vs ECDD Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, ECDD has a market cap of 85.2K. Regarding current trading prices, PRPS is priced at $1.94, while ECDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas ECDD's P/E ratio is -0.01. In terms of profitability, PRPS's ROE is -0.76%, compared to ECDD's ROE of -148.48%. Regarding short-term risk, PRPS and ECDD have similar daily volatility (0.00).Check ECDD's competition here
PRPS vs SUNLQ Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, SUNLQ has a market cap of 79.2K. Regarding current trading prices, PRPS is priced at $1.94, while SUNLQ trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas SUNLQ's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to SUNLQ's ROE of -0.78%. Regarding short-term risk, PRPS is less volatile compared to SUNLQ. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check SUNLQ's competition here
PRPS vs MITJF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, MITJF has a market cap of 70.8K. Regarding current trading prices, PRPS is priced at $1.94, while MITJF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas MITJF's P/E ratio is -0.03. In terms of profitability, PRPS's ROE is -0.76%, compared to MITJF's ROE of +12.11%. Regarding short-term risk, PRPS and MITJF have similar daily volatility (0.00).Check MITJF's competition here
PRPS vs CYIO Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, CYIO has a market cap of 43.6K. Regarding current trading prices, PRPS is priced at $1.94, while CYIO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas CYIO's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to CYIO's ROE of -0.26%. Regarding short-term risk, PRPS is less volatile compared to CYIO. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check CYIO's competition here
PRPS vs HUNTF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, HUNTF has a market cap of 20.4K. Regarding current trading prices, PRPS is priced at $1.94, while HUNTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas HUNTF's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to HUNTF's ROE of -0.01%. Regarding short-term risk, PRPS is less volatile compared to HUNTF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check HUNTF's competition here
PRPS vs FDTC Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, FDTC has a market cap of 8.6K. Regarding current trading prices, PRPS is priced at $1.94, while FDTC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas FDTC's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to FDTC's ROE of -4.54%. Regarding short-term risk, PRPS is less volatile compared to FDTC. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check FDTC's competition here
PRPS vs ARWD Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, ARWD has a market cap of 7.7K. Regarding current trading prices, PRPS is priced at $1.94, while ARWD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas ARWD's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to ARWD's ROE of +0.24%. Regarding short-term risk, PRPS is less volatile compared to ARWD. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check ARWD's competition here
PRPS vs WEIDY Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, WEIDY has a market cap of 7K. Regarding current trading prices, PRPS is priced at $1.94, while WEIDY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas WEIDY's P/E ratio is -0.00. In terms of profitability, PRPS's ROE is -0.76%, compared to WEIDY's ROE of -1.14%. Regarding short-term risk, PRPS and WEIDY have similar daily volatility (0.00).Check WEIDY's competition here
PRPS vs EPOR Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, EPOR has a market cap of 4K. Regarding current trading prices, PRPS is priced at $1.94, while EPOR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas EPOR's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to EPOR's ROE of +0.21%. Regarding short-term risk, PRPS and EPOR have similar daily volatility (0.00).Check EPOR's competition here
PRPS vs VIEWF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, VIEWF has a market cap of 2.7K. Regarding current trading prices, PRPS is priced at $1.94, while VIEWF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas VIEWF's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to VIEWF's ROE of +0.01%. Regarding short-term risk, PRPS is less volatile compared to VIEWF. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check VIEWF's competition here
PRPS vs RAHGF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, RAHGF has a market cap of 2.5K. Regarding current trading prices, PRPS is priced at $1.94, while RAHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas RAHGF's P/E ratio is -0.01. In terms of profitability, PRPS's ROE is -0.76%, compared to RAHGF's ROE of -0.01%. Regarding short-term risk, PRPS and RAHGF have similar daily volatility (0.00).Check RAHGF's competition here
PRPS vs EPORP Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, EPORP has a market cap of 2.1K. Regarding current trading prices, PRPS is priced at $1.94, while EPORP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas EPORP's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to EPORP's ROE of N/A. Regarding short-term risk, PRPS and EPORP have similar daily volatility (0.00).Check EPORP's competition here
PRPS vs WORC Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, WORC has a market cap of 1.9K. Regarding current trading prices, PRPS is priced at $1.94, while WORC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas WORC's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to WORC's ROE of +0.98%. Regarding short-term risk, PRPS and WORC have similar daily volatility (0.00).Check WORC's competition here
PRPS vs DKGH Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, DKGH has a market cap of 1.5K. Regarding current trading prices, PRPS is priced at $1.94, while DKGH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas DKGH's P/E ratio is 0.01. In terms of profitability, PRPS's ROE is -0.76%, compared to DKGH's ROE of +0.35%. Regarding short-term risk, PRPS and DKGH have similar daily volatility (0.00).Check DKGH's competition here
PRPS vs GAFL Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, GAFL has a market cap of 1.5K. Regarding current trading prices, PRPS is priced at $1.94, while GAFL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas GAFL's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to GAFL's ROE of +1.15%. Regarding short-term risk, PRPS and GAFL have similar daily volatility (0.00).Check GAFL's competition here
PRPS vs RBRI Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, RBRI has a market cap of 837. Regarding current trading prices, PRPS is priced at $1.94, while RBRI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas RBRI's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to RBRI's ROE of +0.03%. Regarding short-term risk, PRPS and RBRI have similar daily volatility (0.00).Check RBRI's competition here
PRPS vs FRNV Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, FRNV has a market cap of 596. Regarding current trading prices, PRPS is priced at $1.94, while FRNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas FRNV's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to FRNV's ROE of -0.52%. Regarding short-term risk, PRPS is less volatile compared to FRNV. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check FRNV's competition here
PRPS vs CHFI Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, CHFI has a market cap of 576. Regarding current trading prices, PRPS is priced at $1.94, while CHFI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas CHFI's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to CHFI's ROE of +0.20%. Regarding short-term risk, PRPS is less volatile compared to CHFI. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check CHFI's competition here
PRPS vs AWKS Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, AWKS has a market cap of 0. Regarding current trading prices, PRPS is priced at $1.94, while AWKS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas AWKS's P/E ratio is 0.00. In terms of profitability, PRPS's ROE is -0.76%, compared to AWKS's ROE of N/A. Regarding short-term risk, PRPS and AWKS have similar daily volatility (0.00).Check AWKS's competition here
PRPS vs FLXP Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, FLXP has a market cap of 0. Regarding current trading prices, PRPS is priced at $1.94, while FLXP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas FLXP's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to FLXP's ROE of +0.36%. Regarding short-term risk, PRPS is less volatile compared to FLXP. This indicates potentially lower risk in terms of short-term price fluctuations for PRPS.Check FLXP's competition here
PRPS vs CIAS Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, CIAS has a market cap of 0. Regarding current trading prices, PRPS is priced at $1.94, while CIAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas CIAS's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to CIAS's ROE of N/A. Regarding short-term risk, PRPS and CIAS have similar daily volatility (0.00).Check CIAS's competition here
PRPS vs TSLMF Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, TSLMF has a market cap of 0. Regarding current trading prices, PRPS is priced at $1.94, while TSLMF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas TSLMF's P/E ratio is -0.70. In terms of profitability, PRPS's ROE is -0.76%, compared to TSLMF's ROE of N/A. Regarding short-term risk, PRPS and TSLMF have similar daily volatility (0.00).Check TSLMF's competition here
PRPS vs KTBA Comparison May 2026
PRPS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRPS stands at 17.5M. In comparison, KTBA has a market cap of 0. Regarding current trading prices, PRPS is priced at $1.94, while KTBA trades at $22.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRPS currently has a P/E ratio of -1.28, whereas KTBA's P/E ratio is N/A. In terms of profitability, PRPS's ROE is -0.76%, compared to KTBA's ROE of N/A. Regarding short-term risk, PRPS and KTBA have similar daily volatility (0.00).Check KTBA's competition here